In this study, researchers want to test a new blood test that they have developed which can tell doctors if a person is responding to the drug bevacizumab. Bevacizumab is a type of targeted therapy that works by blocking a growth factor (like a hormone) that makes blood vessels. This growth factor is called VEGF. By blocking VEGF, some cancers i…

The purpose of this study is to help researchers better understand how niraparib is used in the UK and how well it's tolerated by those taking it.Niraparib is a type of drug known as a PARP inhibitor. PARP inhibitors are a relatively new class of drugs known as targeted therapies. In this study the researchers wish to collect real time information …

Maintenance treatment refers to drugs that are given to try to slow or prevent or delay the cancer's return after it has responded to chemotherapy. Currently the PARP inhibitors (one of which is rucaparib) are the only type of targeted treatment licensed for maintenance use in ovarian cancer in the UK. Nivolumab is a different type of targeted t…

This trial looks to answer the question as to whether two different types of anti-cancer drugs, given as maintenance treatment are: safe effective well-tolerated Maintenance treatment is a type of targeted therapy that is given to try to prevent or delay the cancer's return after it has responded to chemotherapy. …